275 related articles for article (PubMed ID: 29848024)
1. An enhanced Lactobacillus reuteri biofilm formulation that increases protection against experimental necrotizing enterocolitis.
Olson JK; Navarro JB; Allen JM; McCulloh CJ; Mashburn-Warren L; Wang Y; Varaljay VA; Bailey MT; Goodman SD; Besner GE
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G408-G419. PubMed ID: 29848024
[TBL] [Abstract][Full Text] [Related]
2. Harvesting the benefits of biofilms: A novel probiotic delivery system for the prevention of necrotizing enterocolitis.
Olson JK; Rager TM; Navarro JB; Mashburn-Warren L; Goodman SD; Besner GE
J Pediatr Surg; 2016 Jun; 51(6):936-41. PubMed ID: 27032609
[TBL] [Abstract][Full Text] [Related]
3. Superior performance of biofilm versus planktonic Limosilactobacillus reuteri in protection of the intestines and brain in a piglet model of necrotizing enterocolitis.
Wala SJ; Sajankila N; Ragan MV; Duff AF; Wickham J; Volpe SG; Wang Y; Conces M; Dumbauld Z; Purayil N; Narayanan S; Rajab A; Mihi B; Bailey MT; Goodman SD; Besner GE
Sci Rep; 2023 Oct; 13(1):17740. PubMed ID: 37872187
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Probiotic Therapy to Protect the Intestines From Injury.
Ragan MV; Wala SJ; Goodman SD; Bailey MT; Besner GE
Front Cell Infect Microbiol; 2022; 12():863949. PubMed ID: 35837474
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial and anti-inflammatory effects of Lactobacillus reuteri in its biofilm state contribute to its beneficial effects in a rat model of experimental necrotizing enterocolitis.
Shelby RD; Mar P; Janzow GE; Mashburn-Warren L; Tengberg N; Navarro JB; Allen JM; Wickham J; Wang Y; Bailey MT; Goodman SD; Besner GE
J Pediatr Surg; 2022 Jul; 57(7):1382-1390. PubMed ID: 34657737
[TBL] [Abstract][Full Text] [Related]
6.
Al-Hadidi A; Navarro J; Goodman SD; Bailey MT; Besner GE
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809097
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by Toll-like receptor 2.
Hoang TK; He B; Wang T; Tran DQ; Rhoads JM; Liu Y
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G231-G240. PubMed ID: 29648878
[TBL] [Abstract][Full Text] [Related]
8.
Wang Y; Jaggers RM; Mar P; Galley JD; Shaffer T; Rajab A; Deshpande S; Mashburn-Warren L; Buzzo JR; Goodman SD; Bailey MT; Besner GE
Brain Behav Immun Health; 2021 Jul; 14():. PubMed ID: 34296201
[TBL] [Abstract][Full Text] [Related]
9. Protective Effects of Lactobacillus reuteri on Intestinal Barrier Function in a Mouse Model of Neonatal Necrotizing Enterocolitis.
Lai Z; Gong F
Am J Perinatol; 2024 May; 41(S 01):e386-e393. PubMed ID: 36368653
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine.
Liu Y; Fatheree NY; Mangalat N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(6):G608-17. PubMed ID: 22207578
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis.
Liu Y; Tran DQ; Fatheree NY; Marc Rhoads J
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G177-86. PubMed ID: 24852566
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis.
Liu Y; Fatheree NY; Dingle BM; Tran DQ; Rhoads JM
PLoS One; 2013; 8(2):e56547. PubMed ID: 23437165
[TBL] [Abstract][Full Text] [Related]
13. A novel probiotic therapeutic in a murine model of
Shelby RD; Janzow GE; Mashburn-Warren L; Galley J; Tengberg N; Navarro J; Conces M; Bailey MT; Goodman SD; Besner GE
Gut Microbes; 2020 Nov; 12(1):1814119. PubMed ID: 32954922
[TBL] [Abstract][Full Text] [Related]
14. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: a sequential analysis.
Hunter C; Dimaguila MA; Gal P; Wimmer JE; Ransom JL; Carlos RQ; Smith M; Davanzo CC
BMC Pediatr; 2012 Sep; 12():142. PubMed ID: 22947597
[TBL] [Abstract][Full Text] [Related]
15. Probiotics and the prevention of necrotizing enterocolitis.
Underwood MA
J Pediatr Surg; 2019 Mar; 54(3):405-412. PubMed ID: 30241961
[TBL] [Abstract][Full Text] [Related]
16.
Liu Y; Tian X; He B; Hoang TK; Taylor CM; Blanchard E; Freeborn J; Park S; Luo M; Couturier J; Tran DQ; Roos S; Wu G; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G824-G838. PubMed ID: 31482733
[TBL] [Abstract][Full Text] [Related]
17. Lactobacillus murinus HF12 colonizes neonatal gut and protects rats from necrotizing enterocolitis.
Isani M; Bell BA; Delaplain PT; Bowling JD; Golden JM; Elizee M; Illingworth L; Wang J; Gayer CP; Grishin AV; Ford HR
PLoS One; 2018; 13(6):e0196710. PubMed ID: 29933378
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Probiotic Potential of
Navarro JB; Mashburn-Warren L; Bakaletz LO; Bailey MT; Goodman SD
Front Microbiol; 2017; 8():489. PubMed ID: 28396655
[TBL] [Abstract][Full Text] [Related]
19. Probiotics for prevention of necrotizing enterocolitis in preterm infants.
AlFaleh K; Anabrees J
Evid Based Child Health; 2014 Sep; 9(3):584-671. PubMed ID: 25236307
[TBL] [Abstract][Full Text] [Related]
20. Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury.
Shiou SR; Yu Y; Guo Y; He SM; Mziray-Andrew CH; Hoenig J; Sun J; Petrof EO; Claud EC
PLoS One; 2013; 8(5):e65108. PubMed ID: 23717690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
